In conclusion, this study showed the increased SERPINA5 expression in GC and indicated that SERPINA5 functions as an oncogene to promote proliferation in GC cells via PI3K/AKT pathway, which may provide a therapeutic target for the future treatment. Here, SERPINA5 is linked to gastric cancer.